Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 2, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

December 31, 2025

Conditions

Continuous Glucose Monitoring

Interventions

DEVICE

Continuous glucose monitor (CGM) Dexcom G7 used in blinded mode

Dexcom G7 used in blinded mode

Trial Locations (1)

The Cleveland Clinic Foundation, Cleveland

All Listed Sponsors

collaborator

DexCom, Inc.

INDUSTRY

lead

The Cleveland Clinic

OTHER

NCT06338748 - Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery | Biotech Hunter | Biotech Hunter